Christopher Henney, Director at Anthera Pharmaceuticals, holds 39.41K shares in Cyclacel Pharmaceuticals (Ticker: CYCC), holds 0.00 shares in Prothena (Ticker: PRTA), holds 0.00 shares in Cascadian Therapeutics (Ticker: CASC).
What is the percentage of profitable transactions made by Christopher Henney?
The percentage of profitable transactions made by Christopher Henney is 57%.
What is the average return per transaction made by Christopher Henney?
The average return per transaction made by Christopher Henney is 32.00%.
What stocks does Christopher Henney hold?
Christopher Henney holds: ANTH, CASC, CYCC, PRTA, SRPT stocks.
What was Christopher Henney’s latest transaction?
Christopher Henney latest transaction was an Uninformative Buy of ―.
What was Christopher Henney's most profitable transaction?
Christopher Henney’s most profitable transaction was an Informative Buy of CASC stock on February 1, 2017. The return on the trade was 136.50%.
What is Christopher Henney's role in Anthera Pharmaceuticals?
Christopher Henney's role in Anthera Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.